Dupilumab-Improved Lung Function Lasts in Children With Asthma
Add-on treatment with dupilumab may improve lung function in children aged 6-11 years with uncontrolled moderate to severe type 2 inflammatory asthma, results from a phase 3 study show.
Source: medscape.com